Network meta-analysis shows image-enhanced endoscopy methods improve adenoma detection rates compared to high-definition white light imaging in colorectal lesion screening
New Camera Tech Finds More Colon Cancer Clues
This network meta-analysis of randomized controlled trials involving 28,663 participants evaluated image-enhanced endoscopy (IEE) methods ag…
A new camera tech helps doctors spot hidden colon cancer clues that standard scopes often miss during routine checkups.
Immune checkpoint inhibitor regimens improve survival versus tyrosine kinase inhibitor monotherapies in advanced hepatocellular carcinoma
The Liver Cancer Treatment That Works Better Depending on Your History
This systematic review and meta-analysis of seventeen studies evaluated immune checkpoint inhibitor (ICI)-based regimens versus tyrosine kin…
Immunotherapy beats older drugs for advanced liver cancer, especially when hepatitis B caused the disease, but benefits depend on your liver…
Robotic simultaneous resection for synchronous colorectal cancer and liver metastases shows feasibility and safety in a meta-analysis
Robots Are Removing Colon Cancer and Liver Tumors in One Operation
This single-arm meta-analysis included 165 patients aged 18 or older with synchronous colorectal cancer and liver metastases.
Robotic surgery safely removes colon cancer and liver tumors in one operation, sparing some patients a second major procedure.
Colon-targeted riboflavin altered fecal microbiome composition in healthy older adults over 12 weeks
A Vitamin Sent Straight to Your Gut Shakes Up the Microbiome
This randomized, double-blind, placebo-controlled trial enrolled 348 healthy older adults (50-70 years) to assess colon-targeted riboflavin …
A clever vitamin B2 formula that travels past the small intestine to the colon nudged the gut microbiome in older adults toward a richer, mo…
Regorafenib plus nivolumab in second-line hepatocellular carcinoma showed safety and survival signals in a Phase IIa trial
Some Liver Cancer Patients Are Surviving Far Longer on a New Drug Combination
This Phase IIa trial evaluated regorafenib plus nivolumab as an add-on therapy in patients with hepatocellular carcinoma who had progressed …
A combination of regorafenib and nivolumab showed unexpectedly long survival in people with advanced liver cancer who had already exhausted …
Systematic review of pediatric post-COVID-19 condition mechanisms and clinical presentations in children and adolescents
Why Some Kids Can't Shake the Effects of COVID
This systematic review examines the pediatric post-COVID-19 condition (PPCC) in children and adolescents.
Some kids still feel sick months after mild COVID due to a perfect storm of immune changes, hidden virus, and gut disruption.
Seladelpar shows improved composite endpoint and ALP reduction in PBC with compensated cirrhosis
New Drug Helps Liver Disease Patients With Cirrhosis
A phase 3 RCT program (RESPONSE and ASSURE studies) in patients with primary biliary cholangitis and compensated cirrhosis found seladelpar …
A new drug lowers liver stress markers in patients with cirrhosis, offering hope where older medicines often failed to stop disease progress…
Quantitative susceptibility mapping shows higher deep gray matter alterations in Wilson's disease compared to healthy controls
New scan findings show brain changes in Wilson's disease patients compared to healthy people
This meta-analysis evaluated quantitative susceptibility mapping (QSM) alterations in deep gray matter among 325 patients with Wilson's dise…
A new scan technique reveals specific brain changes in Wilson's disease patients, showing higher metal buildup in key areas compared to heal…
Systematic review examines immunological analysis of Blau syndrome pathogenesis to define treatment pathways
The Rare Childhood Condition That Rewrites What We Know About Inflammation
This systematic review evaluated immunological analyses of Blau syndrome pathogenesis in patients with this condition.
A rare childhood disease causes inflammation through a completely different pathway than scientists expected, opening new doors for treatmen…
Gastotypes predict Helicobacter pylori infection status in gastric mucosal samples with high accuracy
New Stomach Map Reveals Four Hidden Types
This cohort study analyzed 566 gastric mucosal samples to identify microbial community types associated with Helicobacter pylori infection s…
New stomach map reveals four distinct bacterial neighborhoods, showing stool tests cannot tell the real story happening inside your stomach …
Rituximab exposure is associated with serum sickness in patients with multiple sclerosis, nephrotic syndrome, or immune thrombocytopenia
Can taking Rituximab cause a severe allergic reaction that returns if you take it again?
This retrospective review analyzed 39 published case reports of patients with rituximab-induced serum sickness (RISS).
Taking Rituximab can trigger a delayed allergic reaction that returns in most patients if the drug is given again, so doctors must use extre…
Phase I trial of regorafenib plus ipilimumab and nivolumab shows 27.6% response in MSS colorectal cancer
Who Really Responds to a Stubborn Colon Cancer Combo?
A phase I trial in 29 patients with microsatellite-stable metastatic colorectal cancer tested the combination of regorafenib, ipilimumab, an…
A three-drug combo helped some patients with stubborn colon cancer, and immune markers now predict who will benefit most.